| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM22
|
ADAM metallopeptidase domain 22
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADGRB1
|
adhesion G protein-coupled receptor B1
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AIRE
|
autoimmune regulator
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ANGPT2
|
angiopoietin 2
|
|
APC
|
adenomatous polyposis coli
|
|
APOC1
|
apolipoprotein C-I
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGAP1
|
Rho GTPase activating protein 1
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
AURKB
|
aurora kinase B
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BIN1
|
bridging integrator 1
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRD2
|
bromodomain containing 2
|
|
BRD4
|
bromodomain containing 4
|
|
CA2
|
carbonic anhydrase II
|
|
CALCOCO2
|
calcium binding and coiled-coil domain 2
|
|
CALR
|
calreticulin
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNE1
|
cyclin E1
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CENPE
|
centromere protein E, 312kDa
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHCHD4
|
coiled-coil-helix-coiled-coil-helix domain containing 4
|
|
CHL1
|
cell adhesion molecule L1-like
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COG8
|
component of oligomeric golgi complex 8
|
|
COL10A1
|
collagen, type X, alpha 1
|
|
COL9A1
|
collagen, type IX, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRLF1
|
cytokine receptor-like factor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCX
|
doublecortin
|
|
DGKA
|
diacylglycerol kinase, alpha 80kDa
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD1
|
dopamine receptor D1
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EBF2
|
early B-cell factor 2
|
|
ECT2
|
epithelial cell transforming 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EPHA2
|
EPH receptor A2
|
|
EPX
|
eosinophil peroxidase
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESR1
|
estrogen receptor 1
|
|
F10
|
coagulation factor X
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FGF18
|
fibroblast growth factor 18
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FLCN
|
folliculin
|
|
FOXP3
|
forkhead box P3
|
|
GALNT2
|
polypeptide N-acetylgalactosaminyltransferase 2
|
|
GFER
|
growth factor, augmenter of liver regeneration
|
|
GH1
|
growth hormone 1
|
|
GLDC
|
glycine dehydrogenase (decarboxylating)
|
|
GLI1
|
GLI family zinc finger 1
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H3F3A
|
H3 histone, family 3A
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HBB
|
hemoglobin, beta
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HES5
|
hes family bHLH transcription factor 5
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HOXB13
|
homeobox B13
|
|
HPSE
|
heparanase
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
IFNG
|
interferon, gamma
|
|
IGF2
|
insulin-like growth factor 2
|
|
IL10
|
interleukin 10
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL3
|
interleukin 3
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
INF2
|
inverted formin, FH2 and WH2 domain containing
|
|
IRF9
|
interferon regulatory factor 9
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
IVL
|
involucrin
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
L3MBTL1
|
l(3)mbt-like 1 (Drosophila)
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LAMC2
|
laminin, gamma 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)
|
|
LURAP1
|
leucine rich adaptor protein 1
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MICALL1
|
MICAL-like 1
|
|
MIR155
|
microRNA 155
|
|
MIR200A
|
microRNA 200a
|
|
MIR200B
|
microRNA 200b
|
|
MIR204
|
microRNA 204
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSTN
|
myostatin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYO5A
|
myosin VA (heavy chain 12, myoxin)
|
|
MYO5B
|
myosin VB
|
|
MYO5C
|
myosin VC
|
|
MYOD1
|
myogenic differentiation 1
|
|
MZF1
|
myeloid zinc finger 1
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NEUROG1
|
neurogenin 1
|
|
NEUROG2
|
neurogenin 2
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOX3
|
NADPH oxidase 3
|
|
NOX4
|
NADPH oxidase 4
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NUP98
|
nucleoporin 98kDa
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPN4
|
opsin 4
|
|
OSM
|
oncostatin M
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PADI1
|
peptidyl arginine deiminase, type I
|
|
PARD6A
|
par-6 family cell polarity regulator alpha
|
|
PAX7
|
paired box 7
|
|
PDF
|
peptide deformylase (mitochondrial)
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER1
|
period circadian clock 1
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PKP2
|
plakophilin 2
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PROM1
|
prominin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTK7
|
protein tyrosine kinase 7 (inactive)
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN23
|
protein tyrosine phosphatase, non-receptor type 23
|
|
PVALB
|
parvalbumin
|
|
RAB5A
|
RAB5A, member RAS oncogene family
|
|
RABGEF1
|
RAB guanine nucleotide exchange factor (GEF) 1
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHOA
|
ras homolog family member A
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
SDC1
|
syndecan 1
|
|
SEC13
|
SEC13 homolog (S. cerevisiae)
|
|
SEC23A
|
Sec23 homolog A (S. cerevisiae)
|
|
SEC24B
|
SEC24 family member B
|
|
SEC31A
|
SEC31 homolog A (S. cerevisiae)
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC29A4
|
solute carrier family 29 (equilibrative nucleoside transporter), member 4
|
|
SLC5A10
|
solute carrier family 5 (sodium/sugar cotransporter), member 10
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SQSTM1
|
sequestosome 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK11
|
serine/threonine kinase 11
|
|
SUMO3
|
small ubiquitin-like modifier 3
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TBK1
|
TANK-binding kinase 1
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFB2M
|
transcription factor B2, mitochondrial
|
|
TFF1
|
trefoil factor 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TLR9
|
toll-like receptor 9
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF19
|
tumor necrosis factor receptor superfamily, member 19
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TP53
|
tumor protein p53
|
|
TRIM50
|
tripartite motif containing 50
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
USP8
|
ubiquitin specific peptidase 8
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VWF
|
von Willebrand factor
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
ZFP36
|
ZFP36 ring finger protein
|
